The purpose of this study is to investigate pancreatic adenocarcinoma. This study looks at how different chemotherapy strategies after surgery might affect the condition.
Researchers want to see if changing the chemotherapy plan based on how well the tumor responded to initial treatment can improve outcomes for patients.
- Who can participate: Adults aged 18 and over with surgically removed pancreatic cancer and prior chemotherapy may join. Participants must have a good performance status and meet specific health criteria.
- Study details: Participants will receive chemotherapy tailored to their tumor's response to previous treatment. Some may receive a placebo, which is an inactive substance that looks like the investigational medicine but does not contain any medicine.
How understandable was the trial content above?
Hard to understand
Easy to understand